Produkter

Kvalitetssäkring

Regulatory information

IDL Diagnostics is developing, manufacturing, and distributing in vitro diagnostic products regulated under the IVD directive of the European Union. IDL Diagnostics products TK 210 ELISA are CE-marked and registered as in vitro diagnostic medical devices at the Swedish Medical Products Agency (MPA), the Swedish Competent Authority responsible for market surveillance related to the law on medical devices.

IDL Diagnostics subsidiary, IDL Biotech, is manufacturing and distributing UBC® Rapid, TUBEX® TF, and TUBEX® TF Wash. In addition, TPS® ELISA is also manufactured but only for distribution in China. IDL Biotech’s other ELISA/IRMA products, MonoTotal®, TPS®, TPAcyk™, and UBC are out-licensed and are manufactured and distributed by Beckman Coulter.

TUBEX®, TPS® , UBC® , MonoTotal® and TPAcyk™ are trademarks of IDL Biotech.

IDL Biotech meets high quality standards, and all of the products are developed, manufactured, and supplied to the market according to EN ISO 13485:2016 standardized procedures, and CE marked in accordance with the European IVD directive. 

Investerare

Vi är noterade på NASDAQ First North Growth Market.

Vi vill vara det självklara valet inom vårt segment på de marknader där vi är etablerade. Marknaden för våra produkter är stor och vi är en mindre aktör med en betydande tillväxtpotential än så länge. IDL Diagnostics är unikt för ett bolag av den här storleken.